Compagnie des Transports Strasbourgeois renews mobility policy contract with Keolis
As part of the renewed contract, Keolis will support CTS to achieve its ambitious mobility roadmap, which includes extending its bus rapid transit network and re-structuring the bus network in the Neuhof and Meinau districts.
Keolis has announced that the Compagnie des Transports Strasbourgeois (CTS) has renewed its technical assistance contract with the company for an additional four years. The contract will see Keolis assist the operator in improving its everyday efficiency, so that it can offer an increasingly high-quality, responsible service.
CTS, a local public company jointly owned by the Eurométropole de Strasbourg (EMS) and the Grand Est region, delivers over 400,000 journeys per day. Its network covers the 33 EMS municipalities, which have a population of 500,000.
In order to address the expectations of the energy transition and meet the growing need for mobility, CTS has committed to an ambitious road map that includes recruiting 400 employees by 2025 to support the northern and western extensions of the tram system, extending line G of the bus rapid transit (BRT) network by December 2023, re-structuring the bus network in the Neuhof and Meinau districts by September 2023 and deploying the European Metropolitan Express network (REME) in the imminent future.
Furthermore, Keolis will support CTS in its forecasting – with the aim to better understand mobility practices, lifestyles and the energy transition – while auditing the network’s performance to identify areas for improvement.
Keolis’ support mission will be organised into three areas:
- Cross-functional management to enable CTS to share its experience with other public
transport operators (working groups, seminars, conferences etc.)
- Capitalising on knowledge by setting up monitoring indicators and tools for measuring
and summarising data (dashboards, observatory, press review etc.)
- Advising the operator on its future vision by producing and sharing studies enabling
it to refine its understanding of the issues and deploy new trials and innovations.
If you liked this, you may also be interested in: